Roger Chung

Roger Chung

Company: Celosia Therapeutics

Job title: Chief Scientific Officer

Seminars:

Screening & Selection of the Perfect Vector – An Impossible Challenge 9:30 am

Large diversity of research vectors available, but few are clinically approved Importance of well-designed vector screening program Surprising findings from a 60+ vector screenRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.